Metraipolis › archive › dc_f4dce344494e

Heightened Nontesting Risk Mitigation Blood Donor Screening with Retrospective Transcription-Mediated Amplification Testing during a 2023 Autochthonous… — Europe PMC PMID:41662735

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41662735
DOI
10.4269/ajtmh.25-0139
License (as archived)
solo-consultazione
Archived
2026-11-07T19:04:08.602Z
SHA-256 of the archived text
527194452c5fb66ad04f50feb19ff1ebdcaf94ae8346a0007e36112e605d6f14
Stable URL of this page
https://metraipolis.com/documento/dc_f4dce344494e

How to cite

Heightened Nontesting Risk Mitigation Blood Donor Screening with Retrospective Transcription-Mediated Amplification Testing during a 2023 Autochthonous… — Europe PMC PMID:41662735 — Europe PMC (en), https://europepmc.org/article/MED/41662735 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f4dce344494e (Metraipolis archive dc_f4dce344494e, sha256 527194452c5fb66ad04f50feb19ff1ebdcaf94ae8346a0007e36112e605d6f14)
BibTeX
@misc{dcf4dce344494e,
  title = {Heightened Nontesting Risk Mitigation Blood Donor Screening with Retrospective Transcription-Mediated Amplification Testing during a 2023 Autochthonous… — Europe PMC PMID:41662735},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41662735},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f4dce344494e; sha256 527194452c5fb66ad04f50feb19ff1ebdcaf94ae8346a0007e36112e605d6f14},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41662735. Agents can read the archived copy with the MCP tool read_document.